Literature DB >> 10940895

The antigen dose determines T helper subset development by regulation of CD40 ligand.

C Ruedl1, M F Bachmann, M Kopf.   

Abstract

Although the amount of antigen and the strength of T cell stimulation have been suggested to regulate Th1 vs. Th2 polarization, it remains unclear how the antigen dose and the strength of signal is detected by the T cell and translated into differential cytokine production. Using co-cultures of dendritic cells (DC) and ovalbumin (OVA)-specific CD4+ T cells obtained from RAG-2)(-/-) DO11.10 mice, we show here that high-dose antigen induced Th1 development by up-regulation of CD40 ligand (CD40L), whereas low-dose antigen stimulation failed to induce CD40L and promoted Th2 development. CD40-CD40L interaction was essential for IL-12 production by DC. In the absence, de novo IL-4 production by T cells and autocrine Th2 development was induced. Furthermore, our results demonstrate that LFA-1/ ICAM interaction promotes Th1 differentiation by lowering the antigen dose required for CD40L up-regulation. Thus, we propose that (1) peptide-MHC density and (2) accessory molecules such as LFA-1 determine T helper polarization by regulation of CD40L.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940895     DOI: 10.1002/1521-4141(200007)30:7<2056::AID-IMMU2056>3.0.CO;2-S

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  25 in total

Review 1.  Regulation of TH17 cell differentiation by innate immune signals.

Authors:  Gonghua Huang; Yanyan Wang; Hongbo Chi
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

2.  Quantitative events determine the differentiation and function of helper T cells.

Authors:  Anne O'Garra; Leona Gabryšová; Hergen Spits
Journal:  Nat Immunol       Date:  2011-04       Impact factor: 25.606

3.  Mechanisms by which chronic ethanol feeding limits the ability of dendritic cells to stimulate T-cell proliferation.

Authors:  Ji Fan; Michelle R Edsen-Moore; Lucas E Turner; Robert T Cook; Kevin L Legge; Thomas J Waldschmidt; Annette J Schlueter
Journal:  Alcohol Clin Exp Res       Date:  2010-10-06       Impact factor: 3.455

Review 4.  Modulation of antitumor responses by dendritic cells.

Authors:  Johannes Vieweg; Andrew Jackson
Journal:  Springer Semin Immunopathol       Date:  2005-01

5.  Dendritic cells activated with products released by schistosome larvae drive Th2-type immune responses, which can be inhibited by manipulation of CD40 costimulation.

Authors:  Stephen John Jenkins; Adrian Paul Mountford
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

6.  CD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells.

Authors:  Giandomenica Iezzi; Ivo Sonderegger; Franziska Ampenberger; Nicole Schmitz; Benjamin J Marsland; Manfred Kopf
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-09       Impact factor: 11.205

7.  Interleukin 12 and CD86 Regulate Th1 and Th2 Development Induced by a Range of Antigen Doses Presented by Peyer's Patch and Spleen Cells.

Authors:  Tadashi Yoshida; Satoshi Hachimura; Mina Ishimori; Wataru Ise; Mamoru Totsuka; Akio Ametani; Shuichi Kaminogawa
Journal:  Cytotechnology       Date:  2003-11       Impact factor: 2.058

8.  Dendritic Cells from Spleen, Mesenteric Lymph Node and Peyer's Patch Can Induce the Production of Both IL-4 and IFN-gamma from Primary Cultures of Naive CD4(+) T Cells in a Dose-Dependent Manner.

Authors:  Masanobu Hibi; Satoshi Hachimura; Wataru Ise; Ayuko Sato; Tadashi Yoshida; Tsuyoshi Takayama; Kastumi Sasaki; Takashi Senga; Shuichi Hashizume; Mamoru Totsuka; Shuichi Kaminogawa
Journal:  Cytotechnology       Date:  2003-11       Impact factor: 2.058

9.  Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.

Authors:  Seon-Kyeong Kim; Kristin V Tarbell; Maija Sanna; Mary Vadeboncoeur; Tibor Warganich; Mark Lee; Mark Davis; Hugh O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-20       Impact factor: 11.205

10.  A detailed characterisation of the distribution and presentation of DNA vaccine encoded antigen.

Authors:  Catherine M Rush; Timothy J Mitchell; Paul Garside
Journal:  Vaccine       Date:  2009-12-23       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.